Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

FTC Endorsement Guide Offers Refresher On Social Media Compliance Etiquette

This article was originally published in The Tan Sheet

Executive Summary

FTC’s updated FAQ tackles questions stakeholders have been asking about its Endorsement Guide, including the appropriate way to provide disclosures on social media platforms and the responsibilities of companies using large networks of bloggers and other influencers to promote products.

You may also be interested in...



Supplement Adverse Event Reports Sprout In Fertile Field Of Social Media

Compliance with FDA regulations on supplement marketers reporting serious adverse events means scrutinizing all information about a product on social media pages the same way a firm would comments that consumers or other parties submit by using contact information on product labeling.

P&G, U.K. Ad Authority Clash Over YouTube Channel Disclosures

Firm maintains that disclosures visible to U.K. consumers who watch videos on its "Beauty Recommended" YouTube channel - such as "brought to you by Procter & Gamble" – are adequate and go beyond measures taken by competitors. However, the Advertising Standards Authority says the content's "commercial intent" must be clear even before such videos are opened.

FTC Brings Dot-Com Disclosure Guide To Social Media, Mobile Era

Revised online advertising disclosure guidelines detail FTC’s expectations for how advertisers should craft disclosures in the world of social media and mobile devices.

Related Content

Topics

Related Companies

Latest Headlines
See All
UsernamePublicRestriction

Register

PS107723

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel